Investors Snatch APLS Even Cheaper Than Its Secondary Stock Offering
February 21, 2020 at 15:24 PM EST
Looking back to 44 days ago, Apellis Pharmaceuticals Inc (APLS) priced a 9,500,000 share secondary stock offering at $37.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..